Cohance Lifesciences' promoters, Berhyanda Limited and Jusmiral Holdings Limited, have pledged 21.99 crore equity shares, representing 57.49% of the total capital. These shares are encumbered as security for term loan facilities from various lenders, reported by CSCGlobal Capital Markets (Singapore).